Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
5.72
+0.49 (9.37%)
Apr 1, 2026, 3:02 PM EDT - Market open
Edesa Biotech Employees
Edesa Biotech had 17 employees as of September 30, 2025. The number of employees increased by 1 or 6.25% compared to the previous year.
Employees
17
Change (1Y)
1
Growth (1Y)
6.25%
Revenue / Employee
n/a
Profits / Employee
-$459,761
Market Cap
47.75M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 17 | 1 | 6.25% |
| Sep 30, 2024 | 16 | 0 | - |
| Sep 30, 2023 | 16 | 0 | - |
| Sep 30, 2022 | 16 | 0 | - |
| Sep 30, 2021 | 16 | 4 | 33.33% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Werewolf Therapeutics | 39 |
| Lisata Therapeutics | 21 |
| Atossa Therapeutics | 15 |
| Rallybio | 14 |
| Nutriband | 13 |
| RenovoRx | 10 |
| Telomir Pharmaceuticals | 9 |
EDSA News
- 23 hours ago - Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit - GlobeNewsWire
- 6 days ago - Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment - GlobeNewsWire
- 5 weeks ago - Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study - GlobeNewsWire
- 6 weeks ago - Edesa Biotech Reports Fiscal 1st Quarter 2026 Results - GlobeNewsWire
- 3 months ago - Edesa Biotech Reports Fiscal Year 2025 Results - GlobeNewsWire
- 5 months ago - Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewsWire
- 5 months ago - Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study - GlobeNewsWire
- 8 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewsWire